Skip to main content
. 2021 Sep 29;44(12):2729–2737. doi: 10.2337/dc21-1304

Figure 1.

Figure 1

Glycemic outcomes by treatment and visit. Mean TIR 70–180 mg/dL (A) and mean HbA1c (B) at baseline, month 8, and month 14. The continue CGM group showed CGM for the full 14 months, and the BGM group used BGM for the full 14 months. The discontinue CGM group used CGM through month 8 and then discontinued CGM and used BGM through month 14. Error bars represent 95% CIs.